PDF herunterladen
Synlett 2017; 28(12): 1441-1444
DOI: 10.1055/s-0036-15588166
letter
© Georg Thieme Verlag Stuttgart · New York

A Copper-Catalyzed Synthesis of Functionalized Quinazolines from Isocyanides and Aniline Tri- and Dichloroacetonitrile Adducts through Intramolecular C–H Activation

Manijeh Nematpour
a   Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran   eMail: sa_tabatabai@sbmu.ac.ir
,
Elham Rezaee
a   Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran   eMail: sa_tabatabai@sbmu.ac.ir
,
Sayyed Abbas Tabatabai*
a   Department of Pharmaceutical Chemistry, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran   eMail: sa_tabatabai@sbmu.ac.ir
,
Mehdi Jahani
b   Department of Chemistry, Sharif University of Technology, Tehran, Iran
› Institutsangaben
Weitere Informationen

Publikationsverlauf

Received: 08. Januar 2017

Accepted after revision: 08. März 2017

Publikationsdatum:
11. April 2017 (online)

    Lizenzen und Reprints Alle Artikel dieser Rubrik


Abstract

A novel class of substituted quinazolines were prepared in good yields by a one-pot three-component reaction of isocyanides with adducts of anilines and tri- or dichloroacetonitrile, followed by intramolecular C–H activation, catalyzed by copper(I) iodide with l-proline as a ligand in acetonitrile at room temperature.

Keywords

C–H activation - dichloroacetonitrile - trichloroacetonitrile - copper catalysis - quinazolines - isocyanides

Supporting Information

    Supporting information for this article is available online at https://doi.org/10.1055/s-0036-1588166.
  • Supporting Information
 

  • References and Notes

    • 1a Malecki N. Carato P. Rigo G. Goossens J.-F. Houssin R. Bailly C. Hénichart J.-P. Bioorg. Med. Chem. 2004; 12: 641
      CrossrefPubMed
    • 1b Gundla R. Kazemi R. Sanam R. Muttineni R. Sarma JA. R. P. Dayam R. Neamati N. J. Med. Chem. 2008; 51: 3367
      CrossrefPubMed
  • 2 Fry DW. Kraker AJ. McMichael A. Ambroso LA. Nelson JM. Leopold WR. Connors RW. Bridges AJ. Science 1994; 265: 1093
    CrossrefPubMed
    • 3a Herget T. Freitag M. Morbitzer M. Kupfer R. Stamminger T. Marschall M. Antimicrob. Agents Chemother. 2004; 48: 4154
      CrossrefPubMed
    • 3b Chien T.-C. Chen C.-S. Yu F.-H. Chern J.-W. Chem. Pharm. Bull. 2004; 52: 1422
      CrossrefPubMed
  • 4 Henderson EA. Bavetsias V. Theti DS. Wilson SC. Clauss R. Jackman AL. Bioorg. Med. Chem. 2006; 14: 5020
    CrossrefPubMed
    • 5a Kunes J. Bazant J. Pour M. Waisser K. Slosárek M. Janota J. Farmaco 2000; 55: 725
      CrossrefPubMed
    • 5b Waisser K. Gregor J. Dostál H. Kunes J. Kubicová L. Klimesová V. Kaustová J. Farmaco 2001; 56: 803
      CrossrefPubMed
    • 6a Lewerenz A. Hentschel S. Vissiennon Z. Michael S. Nieber K. Drug Dev. Res. 2003; 58: 420
      Crossref
    • 6b Colotta V. Catarzi D. Varano F. Lenzi O. Filacchioni G. Costagli C. Galli A. Ghelardini C. Galeotti N. Gratteri P. Sgrignani J. Deflorian F. Moro S. J. Med. Chem. 2006; 49: 6015
      CrossrefPubMed
  • 7 Mendes da Silva JF. Walters M. Al-Damluji S. Ganellin CR. Bioorg. Med. Chem. 2008; 16: 7254
    CrossrefPubMed
    • 8a Lüth A. Löwe W. Eur. J. Med. Chem. 2008; 43: 1478
      CrossrefPubMed
    • 8b Rewcastle GW. Palmer BD. Bridges AJ. Showalter HD. H. Sun L. Nelson J. McMichael A. Kraker AJ. Fry DW. Denny WA. J. Med. Chem. 1996; 39: 918
      CrossrefPubMed
    • 9a Undheim K. Benneche T. In: Comprehensive Heterocyclic Chemistry II . Vol. 6. Katritzky AR. Rees CW. Scriven EV. F. Chap. 6.02 Pergamon; Oxford: 1998: 93
      Google Scholar
    • 9b Connolly DJ. Cusack D. O’Sullivan TP. Guiry PJ. Tetrahedron 2005; 61: 10153
      Crossref
    • 9c Michael JP. Nat. Prod. Rep. 2003; 20: 476
      CrossrefPubMed
    • 9d Shreder KR. Wong MS. Nomanbhoy T. Leventhal PS. Fuller SR. Org. Lett. 2004; 6: 3715
      CrossrefPubMed
    • 9e Costa M. Ca ND. Gabriele B. Massera C. Salerno G. Soliani M. J. Org. Chem. 2004; 69: 2469
      CrossrefPubMed
    • 9f Wiedemann SH. Ellman JA. Bergman RG. J. Org. Chem. 2006; 71: 1969
      CrossrefPubMed
    • 9g Fekner T. Müller-Bunz H. Guiry PJ. Org. Lett. 2006; 8: 5109
      CrossrefPubMed
    • 9h Kappe CO. Angew. Chem. Int. Ed. 2004; 43: 6250
      CrossrefPubMed
    • 9i Ferrini S. Ponticelli F. Taddei M. Org. Lett. 2007; 9: 69
      CrossrefPubMed
    • 9j Mizuno T. Okamoto N. Ito T. Miyata Y. Tetrahedron Lett. 2000; 41: 1051
      Crossref
    • 10a Sun C.-L. Li B.-J. Shi Z.-J. Chem. Rev. 2011; 111: 1293
      CrossrefPubMed
    • 10b Engle KM. Mei T.-S. Wasa M. Yu J.-Q. Acc. Chem. Res. 2012; 45: 788
      CrossrefPubMed
    • 10c Ackermann L. Acc. Chem. Res. 2014; 47: 281
      CrossrefPubMed
    • 10d Neufeldt SR. Sanford MS. Acc. Chem. Res. 2012; 45: 936
      CrossrefPubMed
    • 10e Colby DA. Tsai AS. Bergman RG. Ellman JA. Acc. Chem. Res. 2012; 45: 814
      CrossrefPubMed
    • 11a Zhu C. Yi M. Wei D. Chen X. Wu Y. Cui X. Org. Lett. 2014; 16: 1840
      CrossrefPubMed
    • 11b Lu J. Jin Y. Liu H. Jiang Y. Fu H. Org. Lett. 2011; 13: 3694
      CrossrefPubMed
    • 11c Huang H. Ji X. Tang X. Zhang M. Li X. Jiang H. Org. Lett. 2013; 15: 6254
      CrossrefPubMed
    • 11d Oda Y. Hirano K. Satoh T. Miura M. Org. Lett. 2012; 14: 664
      CrossrefPubMed
    • 11e Selvaraju M. Sun C.-M. Adv. Synth. Catal. 2014; 356: 1329
      Crossref
    • 11f Sang P. Xie Y. Zou J. Zhang Y. Org. Lett. 2012; 14: 3894
      CrossrefPubMed
    • 11g Wang Q. Schreiber SL. Org. Lett. 2009; 11: 5178
      CrossrefPubMed
    • 11h Xu H. Fu H. Chem. Eur. J. 2012; 18: 1180
      CrossrefPubMed
    • 11i Mitsuda S. Fujiwara T. Kimigafukuro K. Monguchi D. Mori A. Tetrahedron 2012; 68: 3585
      Crossref
    • 11j Monguchi D. Fujiwara T. Furukawa H. Mori A. Org. Lett. 2009; 11: 1607
      CrossrefPubMed
    • 12a Yavari I. Nematpour M. Damghani T. Tetrahedron Lett. 2014; 55: 1323
      Crossref
    • 12b Yavari I. Nematpour M. Helv. Chim. Acta 2014; 97: 1132
      Crossref
    • 12c Yavari I. Nematpour M. Mol. Divers. 2015; 19: 703
      CrossrefPubMed
  • 13 Yavari I. Nematpour M. Sodagar E. Synlett 2013; 24: 161
    Artikel in Thieme Connect
  • 14 N-Phenyl-2-(trichloromethyl)quinazolin-4-amine (5a); Typical Procedure A mixture of PhNH2 (2a; 1 mmol) and Cl3CCN (1a; 1 mmol) was stirred for 5 min, and then a mixture of PhNC (4a; 1.5 mmol), CuI (0.10 mmol), Cs2CO3 (2.0 mmol), and l-proline (20 mol%) in MeCN (2 mL) was slowly added. The mixture was stirred at r.t. for 5 h until the reaction was complete [TLC, EtOAc–hexane (1:4)]. The mixture was then diluted with CH2Cl2 (2 mL) and aq NH4Cl (3 mL). The resulting mixture was stirred for 30 min, and then the phases were separated. The aqueous phase was extracted with CH2Cl2, and the combined organic fractions were dried (Na2SO4), filtered, and concentrated under reduced pressure. The resulting solid was collected by filtration and washed with hexane to give a cream-colored powder; yield: 0.29 g (85%); mp 188–190 °C. IR (KBr): 3344, 1604, 1585, 1164, 759 cm−1. 1H NMR (500 MHz, CDCl3): δ = 5.05 (s, 1 H, NH), 7.29–7.35 (m, 3 H, Ph), 7.48 (d, 3 J = 7.7, 2 H, Ar), 7.55 (t, 3 J = 8.1, 1 H, Ar), 7.62 (t, 3 J = 8.1, 1 H, Ar), 8.02 (d, 3 J = 8.1, 1 H, Ar), 8.26 (d, 3 J = 8.1, 1 H, Ar). 13C NMR (125.7 MHz, CDCl3): δ = 90.6 (CCl3), 127.2 (CH), 127.9 (2 CH), 128.1 (CH), 128.6 (2 CH), 129.4 (CH), 130.1 (CH), 131.4 (CH), 133.8 (C), 142.7 (C), 148.0 (C), 156.2 (C), 160.1 (C). MS: m/z (%) = 338 (11) [M + 1], 259 (12), 244 (18), 128 (24), 116 (100), 92 (56), 77 (60). Anal. Calcd for C15H10Cl3N3 (338.62): C, 53.20; H, 2.98; N, 12.41. Found: C, 53.18; H, 2.95; N, 12.49.
  • 15 Yang D. An B. Wei W. Tian L. Huang B. Wang H. ACS Comb. Sci. 2015; 17: 113
    CrossrefPubMed